Global Sexually Transmitted Diseases Testing Market Growth (Status and Outlook) 2023-2029

Global Sexually Transmitted Diseases Testing Market Growth (Status and Outlook) 2023-2029

Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles.

LPI (LP Information)' newest research report, the “Sexually Transmitted Diseases Testing Industry Forecast” looks at past sales and reviews total world Sexually Transmitted Diseases Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Sexually Transmitted Diseases Testing sales for 2023 through 2029. With Sexually Transmitted Diseases Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sexually Transmitted Diseases Testing industry.

This Insight Report provides a comprehensive analysis of the global Sexually Transmitted Diseases Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sexually Transmitted Diseases Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sexually Transmitted Diseases Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sexually Transmitted Diseases Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sexually Transmitted Diseases Testing.

The global Sexually Transmitted Diseases Testing market size is projected to grow from US$ 72790 million in 2022 to US$ 100180 million in 2029; it is expected to grow at a CAGR of 4.7% from 2023 to 2029.

The Americas will be the major revenue contributor to the sexually transmitted diseases testing market owing to the advanced healthcare infrastructure in this region. Also, the increasing awareness about STD testing and the initiatives taken by governments to promote various tests will drive the growth of the STD screening market in this region.

This report presents a comprehensive overview, market shares, and growth opportunities of Sexually Transmitted Diseases Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Chlamydia Testing
Gonorrhea Testing
Syphilis Testing
HIV Testing
HSV Testing
HPV Testing
Chancroid Testing
Other

Segmentation by application
Clinics
Hospitals
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BioMerieux
F. Hoffmann La Roche
BD
Abbott
Bio-Rad Laboratories
Abbott
Qiagen

Please note: The report will take approximately 2 business days to prepare and deliver.